This means that Jumbo has overtaken Hollywood title Moana 2 to become Indonesia’s second-highest-grossing animated title at the box office (Frozen 2 still remains the all-time frontrunner).

Colossal Biosciences, known for its ambitious “de-extinction” efforts, recently announced three snowy-white dire wolf pups named Romulus, Remus, and Khaleesi, marking the first time the ...

Neurocrine Biosciences, Inc. has shown significant growth since its 1996 IPO, with a current stock price around $100, reflecting an 850% increase. Ingrezza is the flagship, >$2bn p.a. selling product.

In this article, we are going to take a look at where Pacira BioSciences, Inc. (NASDAQ:PCRX) stands against other best pharma stocks to buy for long term growth. With big American pharmaceutical ...

We are initiating coverage of Bright Minds Biosciences with a Buy rating, as we believe the stock is undervalued. We see a key catalyst in the Phase 2 data readout for BMB-101, which is expected ...

Skye Bioscience (SKYE) announced new preclinical data for its novel CB1 antibody, nimacimab. In a murine diet-induced obesity model, after 25 days of treatment, results demonstrated: Greater than ...

Precision BioSciences (DTIL) announced that the FDA has granted fast track designation for PBGENE-HBV, the company’s lead wholly owned in vivo gene editing program designed to cure chronic ...

Precision BioSciences Touts Encouraging Initial Safety And Antiviral Activity Of Hepatitis B Treatment Candidate Precision BioSciences reports early PBGENE-HBV trial data showing safety and ...

In this article, we are going to take a look at where Regencell Bioscience Holdings Ltd. (NASDAQ:RGC) stands against other micro-, small-cap firms that dominate Thursday’s gains. The stock ...

We're fourth in the UK in terms of the quality of our research (REF 2021). In the REF 2021, 98 per cent of research and impact from the School of Biosciences has been classed as world-leading or ...

The life sciences company Solid Biosciences is merging with the privately-held gene therapy company AavantiBio in a deal which is expected to result in a combined sum of $215 million in cash and ...